ESR1 and tuberculosis: We selected drugs with little effect on cardiovascular circulation and the central nervous system from the hits, and we focused further work on five drugs with different targets: raloxifene, selective estrogen receptor modulator (SERM), rifampin, anti‐tuberculosis, pranlukast, CysLT1 antagonist, zileuton, 5‐LOX inhibitor, pioglitazone, PPARγ agonist for the next analysis.